Protalix BioTherapeutics PE Ratio 2010-2025 | PLX

Protalix BioTherapeutics PE ratio as of June 11, 2025 is 87.00.

Current and historical p/e ratio for Protalix BioTherapeutics (PLX) from 2010 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Protalix BioTherapeutics PE Ratio 2010-2025 | PLX

Current and historical p/e ratio for Protalix BioTherapeutics (PLX) from 2010 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.